Stocks of biotechnology companies, including makers of cancer drugs, dropped Tuesday morning after the news of Pazdur’s looming departure.
Stocks of biotechnology companies, including makers of cancer drugs, dropped Tuesday morning after the news of Pazdur’s looming departure.